Responder Characteristics to a Single Oral Dose of Cholinesterase Inhibitor: A Double-Blind Placebo-Controlled Study withTacrine in Alzheimer P atients

O. Almkvist; V. Jelic; K. Amberla; E. Hellström-Lindahl; L. Meurling; A. Nordberg

doi:10.1159/000051232

Responder Characteristics to a Single Oral Dose of Cholinesterase Inhibitor: A Double-Blind Placebo-Controlled Study withTacrine in Alzheimer P atients

Dementia and Geriatric Cognitive Disorders ◽

10.1159/000051232 ◽

2000 ◽

Vol 12 (1) ◽

pp. 22-32 ◽

Cited By ~ 47

Author(s):

O. Almkvist ◽

V. Jelic ◽

K. Amberla ◽

E. Hellström-Lindahl ◽

L. Meurling ◽

...

Keyword(s):

Oral Dose ◽

Single Oral Dose ◽

Cholinesterase Inhibitor ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Improvement of Primary Dysmenorrhea Caused by a Single Oral Dose of Vitamin D: Results of a Randomized, Double-blind, Placebo-Controlled Study

Archives of Internal Medicine ◽

10.1001/archinternmed.2011.715 ◽

2012 ◽

Vol 172 (4) ◽

pp. 366 ◽

Cited By ~ 57

Author(s):

Antonino Lasco

Keyword(s):

Vitamin D ◽

Oral Dose ◽

Single Oral Dose ◽

Controlled Study ◽

Primary Dysmenorrhea ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

16: A phase 3 randomized, double-blind, placebo-controlled study to confirm the efficacy and safety of a single, oral dose of SYM-1219, a granule formulation containing 2 grams of secnidazole, for the treatment of bacterial vaginosis

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2016.09.017 ◽

2016 ◽

Vol 215 (6) ◽

pp. S821-S822 ◽

Cited By ~ 4

Author(s):

J. Schwebke ◽

F. Morgan ◽

W. Koltun ◽

H. Pentikis ◽

N. Adetoro ◽

...

Keyword(s):

Oral Dose ◽

Bacterial Vaginosis ◽

Single Oral Dose ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Granule Formulation

Download Full-text

Faculty Opinions recommendation of Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717348019.792703129 ◽

2012 ◽

Author(s):

Moamar Al-Jefout

Keyword(s):

Vitamin D ◽

Oral Dose ◽

Single Oral Dose ◽

Controlled Study ◽

Primary Dysmenorrhea ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A single oral dose of Silodosin and Diclofenac sodium is effective in reducing pain after ureteric stent removal: a prospective, randomized, double blind placebo-controlled study

SpringerPlus ◽

10.1186/s40064-015-1662-7 ◽

2016 ◽

Vol 5 (1) ◽

Cited By ~ 2

Author(s):

Goto Gangkak ◽

Ram Dayal Teli ◽

Sher Singh Yadav ◽

Vinay Tomar ◽

Shivam Priyadarshi ◽

...

Keyword(s):

Oral Dose ◽

Single Oral Dose ◽

Diclofenac Sodium ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Ureteric Stent ◽

Stent Removal

Download Full-text

PS-5-6 A Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Effect of a Single Oral Dose of GSK958108 on Ejaculation Latency Time in Male Patients Suffering From Premature Ejaculation

Journal of Sexual Medicine ◽

10.1016/j.jsxm.2020.04.051 ◽

2020 ◽

Vol 17 (6) ◽

pp. S135

Author(s):

F. Migliorini ◽

A. Marcer ◽

A. Tafuri ◽

G. Cacciamani ◽

A.B. Porcaro ◽

...

Keyword(s):

Oral Dose ◽

Single Oral Dose ◽

Premature Ejaculation ◽

Latency Time ◽

Double Blind ◽

Double Blind Placebo ◽

Ejaculation Latency ◽

Parallel Group Study ◽

Parallel Group ◽

Male Patients

Download Full-text

Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR

Heart Rhythm ◽

10.1016/j.hrthm.2016.04.012 ◽

2016 ◽

Vol 13 (9) ◽

pp. 1777-1783 ◽

Cited By ~ 14

Author(s):

Jonathan P. Piccini ◽

Edward L.C. Pritchett ◽

Beth A. Davison ◽

Gad Cotter ◽

Laura E. Wiener ◽

...

Keyword(s):

Atrial Fibrillation ◽

Oral Dose ◽

Normal Sinus Rhythm ◽

Controlled Study ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Recent Onset ◽

Normal Sinus ◽

Onset Atrial Fibrillation

Download Full-text

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of the GPR40 Agonist TAK-875: Results From a Double-Blind, Placebo-Controlled Single Oral Dose Rising Study in Healthy Volunteers

The Journal of Clinical Pharmacology ◽

10.1177/0091270011409230 ◽

2012 ◽

Vol 52 (7) ◽

pp. 1007-1016 ◽

Cited By ~ 61

Author(s):

Himanshu Naik ◽

Majid Vakilynejad ◽

Jingtao Wu ◽

Prabhakar Viswanathan ◽

Nobuhito Dote ◽

...

Keyword(s):

Oral Dose ◽

Healthy Volunteers ◽

Single Oral Dose ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of Taranabant, a Novel Selective Cannabinoid-1 Receptor Inverse Agonist, for the Treatment of Obesity: Results From a Double-Blind, Placebo-Controlled, Single Oral Dose Study in Health

The Journal of Clinical Pharmacology ◽

10.1177/0091270008314467 ◽

2008 ◽

Vol 48 (4) ◽

pp. 418-427 ◽

Cited By ~ 37

Author(s):

Carol Addy ◽

Susie Li ◽

Nancy Agrawal ◽

Julie Stone ◽

Anup Majumdar ◽

...

Keyword(s):

Oral Dose ◽

Single Oral Dose ◽

Inverse Agonist ◽

Double Blind ◽

Double Blind Placebo ◽

Cannabinoid 1 Receptor ◽

Dose Study ◽

Treatment Of Obesity ◽

Receptor Inverse Agonist

Download Full-text

PD28-08 A DOUBLE-BLIND, PLACEBO-CONTROLLED PARALLEL GROUP STUDY TO EVALUATE THE EFFECT OF A SINGLE ORAL DOSE OF GSK958108 ON EJACULATION LATENCY TIME IN MALE PATIENTS SUFFERING FROM PREMATURE EJACULATION

The Journal of Urology ◽

10.1097/01.ju.0000555935.59113.a8 ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

Filippo Migliorini ◽

Anna Marcer* ◽

Paolo Bettica ◽

Luigi Ziviani ◽

Jesper Lund ◽

...

Keyword(s):

Oral Dose ◽

Single Oral Dose ◽

Premature Ejaculation ◽

Latency Time ◽

Double Blind ◽

Double Blind Placebo ◽

Ejaculation Latency ◽

Parallel Group Study ◽

Parallel Group ◽

Male Patients

Download Full-text

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF A CHOLINESTERASE INHIBITOR IN DELIRIUM

Innovation in Aging ◽

10.1093/geroni/igx004.4081 ◽

2017 ◽

Vol 1 (suppl_1) ◽

pp. 1115-1115

Author(s):

M. Verny ◽

A. Breining ◽

A. Meziere ◽

C. Thomas ◽

A. Grancher ◽

...

Keyword(s):

Cholinesterase Inhibitor ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text